approval
saveLAMOTRIGINE — FDA approval
community read0 votes
Sponsor: AUROBINDO PHARMA. Form: TABLET, FOR SUSPENSION. Route: ORAL
view source ↗Data sources
last refreshed 6mo ago
Found something off?
drug timeline · 8
- approvalLAMOTRIGINE — FDA approvalApr 17, 2026 · 217d ago
- approvalLAMOTRIGINE — FDA approvalApr 17, 2026 · 217d ago
- approvalLAMOTRIGINE — FDA approvalApr 10, 2026 · 224d ago
- approvalLAMOTRIGINE — FDA approvalApr 10, 2026 · 224d ago
- approvalLAMOTRIGINE — FDA approvalApr 10, 2026 · 224d ago
- approvalLAMOTRIGINE — FDA approvalApr 10, 2026 · 224d ago
- approvalLAMOTRIGINE — FDA approvalApr 10, 2026 · 224d ago
- approvalLAMOTRIGINE — FDA approvalApr 9, 2026 · 225d ago
same company · ±60 days · 6
- approvalacetaminophen ER: TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalDec 29, 2025
- approvalTRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalDec 29, 2025
- approvaltramadol hydrochloride ER: TRAMADOL HYDROCHLORIDE — FDA approvalDec 29, 2025
- approvalpseudoephedrine hydrochloride ER: PSEUDOEPHEDRINE HYDROCHLORIDE — FDA approvalDec 29, 2025
- approvalLOPERAMIDE HYDROCHLORIDE: LOPERAMIDE HYDROCHLORIDE — FDA approvalDec 29, 2025
- approvalTRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalDec 29, 2025
comments(0)
5-min edit window · permanent after that